Pluri Inc. Increase (Decrease) in Accounts Payable, Trade
Pluri Inc. (PLUR) reported Increase (Decrease) in Accounts Payable, Trade of -$77.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-09-10
- Pluri Inc. increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was -$39.00K, a 533.33% decline year-over-year.
- Pluri Inc. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was -$261.00K.
- Pluri Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was $122.00K, a 771.43% increase year-over-year.
- Pluri Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was $101.00K, a 32.67% decline year-over-year.
- Pluri Inc. increase (decrease) in accounts payable, trade for fiscal 2026 was -$77.00K.
- Pluri Inc. increase (decrease) in accounts payable, trade for fiscal 2025 was -$235.00K.
- Pluri Inc. increase (decrease) in accounts payable, trade for fiscal 2024 was -$778.00K.
- Pluri Inc. increase (decrease) in accounts payable, trade for fiscal 2023 was -$22.00K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | -$300.00K derived: sum of 2 quarters · filed 2026-09-10 | -$178.00K derived: sum of 3 quarters · filed 2026-09-10 | -$77.00K 10-K · filed 2026-09-10 |
| 2026-03-31 | -$261.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-14 | -$139.00K derived: sum of 2 quarters · filed 2026-05-14 | -$38.00K 10-Q · filed 2026-05-14 | -$29.00K derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-12-31 | $122.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | $223.00K 10-Q · filed 2026-02-12 | $232.00K derived: sum of 3 quarters · filed 2026-09-10 | -$176.00K derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-09-30 | $101.00K 10-Q · filed 2025-11-12 | $110.00K derived: sum of 2 quarters · filed 2026-09-10 | -$298.00K derived: sum of 3 quarters · filed 2026-09-10 | -$284.00K derived: sum of 4 quarters · filed 2026-09-10 |
| 2025-06-30 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | -$399.00K derived: sum of 2 quarters · filed 2026-09-10 | -$385.00K derived: sum of 3 quarters · filed 2026-09-10 | -$235.00K 10-K · filed 2026-09-10 |
| 2025-03-31 | -$408.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-14 | -$394.00K derived: sum of 2 quarters · filed 2026-05-14 | -$244.00K 10-Q · filed 2026-05-14 | -$280.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | $164.00K 10-Q · filed 2026-02-12 | $128.00K derived: sum of 3 quarters · filed 2026-02-12 | |
| 2024-09-30 | $150.00K 10-Q · filed 2025-11-12 | $114.00K derived: sum of 2 quarters · filed 2025-11-12 | ||
| 2024-06-30 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17 | -$778.00K 10-K · filed 2025-09-17 | ||
| 2024-03-31 | -$742.00K 10-Q · filed 2025-05-13 | |||
| 2023-06-30 | -$22.00K 10-K · filed 2023-09-12 | |||
| 2022-06-30 | -$758.00K 10-K · filed 2023-09-12 | |||
| 2021-06-30 | $578.00K 10-K · filed 2022-09-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |